Article
MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?
Current opinion in genetics & development - 1 Apr 2007
Chadwick Lisa Helbling, Wade Paul A
Abstract excerpt
Rett syndrome is a progressive neurological disorder caused by mutations in the methyl-DNA binding protein MeCP2. The longstanding model depicting MeCP2 as a transcriptional repressor predicts that the Rett syndrome phenotype probably results from misregulation of MeCP2 target genes. Somewhat unexpectedly, the identification of such targets has proven challenging. The recent identification of two MeCP2 targets,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
